Xponance Inc. Trims Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Xponance Inc. cut its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU) by 6.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,024 shares of the company’s stock after selling 1,935 shares during the period. Xponance Inc.’s holdings in DocuSign were worth $1,607,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of DOCU. AQR Capital Management LLC increased its stake in DocuSign by 147.4% during the third quarter. AQR Capital Management LLC now owns 1,908,500 shares of the company’s stock worth $80,157,000 after purchasing an additional 1,136,948 shares during the period. Jupiter Asset Management Ltd. increased its stake in shares of DocuSign by 166.4% during the third quarter. Jupiter Asset Management Ltd. now owns 1,344,703 shares of the company’s stock worth $56,478,000 after buying an additional 839,883 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of DocuSign by 77.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company’s stock worth $51,057,000 after buying an additional 531,682 shares during the period. International Assets Investment Management LLC increased its stake in shares of DocuSign by 4,438.8% during the fourth quarter. International Assets Investment Management LLC now owns 521,912 shares of the company’s stock worth $31,028,000 after buying an additional 510,413 shares during the period. Finally, Vanguard Group Inc. increased its stake in shares of DocuSign by 2.4% during the third quarter. Vanguard Group Inc. now owns 20,982,387 shares of the company’s stock worth $881,260,000 after buying an additional 482,472 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other DocuSign news, insider Stephen Shute sold 15,109 shares of the stock in a transaction on Tuesday, March 19th. The stock was sold at an average price of $57.02, for a total value of $861,515.18. Following the completion of the transaction, the insider now owns 8,959 shares in the company, valued at $510,842.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other DocuSign news, insider Stephen Shute sold 15,109 shares of the stock in a transaction on Tuesday, March 19th. The stock was sold at an average price of $57.02, for a total value of $861,515.18. Following the completion of the transaction, the insider now owns 8,959 shares in the company, valued at $510,842.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Allan C. Thygesen sold 7,680 shares of the stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the transaction, the chief executive officer now owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The disclosure for this sale can be found here. Over the last quarter, insiders sold 54,871 shares of company stock worth $3,176,199. 17.80% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on DOCU shares. Wells Fargo & Company cut their target price on shares of DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research note on Monday, February 5th. Royal Bank of Canada restated a “sector perform” rating and set a $59.00 target price on shares of DocuSign in a research note on Friday, April 12th. UBS Group upgraded shares of DocuSign from a “sell” rating to a “neutral” rating and upped their target price for the stock from $48.00 to $62.00 in a research note on Friday, April 12th. Morgan Stanley upgraded shares of DocuSign from an “underweight” rating to an “equal weight” rating and upped their target price for the stock from $49.00 to $64.00 in a research note on Tuesday, January 16th. Finally, JMP Securities restated a “market outperform” rating and set a $84.00 target price on shares of DocuSign in a research note on Friday, April 12th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $60.25.

DocuSign Price Performance

DocuSign stock opened at $56.71 on Wednesday. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76. The business has a 50 day simple moving average of $56.11 and a 200-day simple moving average of $52.48. The stock has a market capitalization of $11.65 billion, a PE ratio of 157.53, a price-to-earnings-growth ratio of 4.87 and a beta of 0.89.

DocuSign (NASDAQ:DOCU) last released its quarterly earnings results on Thursday, March 7th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. The business had revenue of $712.39 million during the quarter, compared to analysts’ expectations of $698.05 million. As a group, equities research analysts anticipate that DocuSign, Inc. will post 0.86 EPS for the current year.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.